About the Cluster of Excellence PMI

More and more people in industrial nations are suffering from chronic inflammatory diseases such as Crohn’s disease, psoriasis, diabetes and rheumatism. In the Cluster of Excellence 2167 “Precision Medicine in Chronic Inflammation” (PMI), scientists from various medical disciplines and fundamental research are working together on an interdisciplinary basis to significantly improve the diagnosis, treatment and prevention of these diseases.

Their vision is to achieve complete control over the diseases – at every stage and as early as possible.

 

More about the Cluster of Excellence PMI

Mission

The members of the PMI  want to establish precision medicine in chronic inflammation, which takes the individuality of a person and their environment into account. Clinical studies and translation are at the core of this work - fundamental research results should be transferred as quickly as possible from bench to bedside.

Organization

Around 400 researching clinicians and scientists from various departments, from fundamental research and the hospital are members of the Cluster of Excellence PMI. They elect the Steering Committee, the cluster's decision-making body. This committee is supported and advised by the Scientific Advisory Board. The Steering Committee also elects the Executive Group.

 

 

More about the organization of the Cluster of Excellence PMI

group
© Sascha Klahn

Group photo taken at the 2025 retreat in Travemünde

Funding

The Cluster of Excellence in Precision Medicine in Chronic Inflammation (PMI) will enter its second funding phase (2026–2032) in 2026, marking its fourth consecutive round of funding for inflammation research. The Joint Science Conference (GWK) of the Federal Government and the Länder, together with the German Research Foundation (DFG), has approved the funding as part of the Excellence Strategy.

The cluster builds on the successful predecessor ‘Inflammation at Interfaces’ (2007–2018) as well as the first PMI funding period (2019–2025). Around 400 researchers from eight partner institutions are involved in the interdisciplinary network.

Hosts

The interdisciplinary research network has around 400 members in the following host institutions in Schleswig-Holstein

and as a clinical partner:

Predecessor Cluster

The work of PMI builds upon the findings and structures established by its predecessor cluster “Inflammation at Interfaces”, which has conducted more than ten years of successful research on inflammation in Schleswig-Holstein.

 

 

 

More about the Cluster of Excellence "INflammation at interfaces"